Hege Elisabeth Sollie-Zetlmayer
CIK: 0002142653
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PTCT
PTC THERAPEUTICS, INC.
Director
Discretionary Trading P&L
Holdings
About Sollie-Zetlmayer Hege Elisabeth
Sollie-Zetlmayer Hege Elisabeth (SEC CIK 0002142653) files insider reports with the SEC as Director of PTC THERAPEUTICS, INC. (PTCT).
Signal8 holds 2 ownership filings by Sollie-Zetlmayer Hege Elisabeth (1 Form 3, 1 Form 4), filed on Jul 30, 2026. Those filings report 2 transactions, the latest on Jul 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sollie-Zetlmayer Hege Elisabeth's filings is in WARREN, NJ.
Recent filings by Sollie-Zetlmayer Hege Elisabeth
- Jul 28, 2026: Grants or awards of PTCT shares (2 lines, Form 4, code A).
Other insiders filing for PTC THERAPEUTICS, INC. (PTCT)
- SCHMERTZLER MICHAEL, Director
- Boulding Mark Elliott, EXEC. VP AND CLO
- STEELE GLENN JR MD PHD, Director
- Klein Matthew B., CHIEF EXECUTIVE OFFICER
- Gravier Pierre, CHIEF FINANCIAL OFFICER
- Smith Mary L., Director